Erika Santos Horta, MD

Full Member

Research Program:

Cancer Therapeutics

Faculty Rank:

Assistant Research Professor

Campus:

University of Arkansas for Medical Sciences

College:

College of Medicine

Department:

Neurology

Cancer Research Interest

Disease Site Focus: Brain
Research Focus Area: Treatment, Diagnosis/ Prognosis
Type of Research: Clinical
Research Keywords: brain tumors, neurofibromatosis, gliomas, meningiomas, clinical trials
Research Interest Statement: My mission is to improve the care of patients with brain tumors through developing clinical trials, disseminating knowledge and by listening to my patients experiences.

“NRG-BN011 A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma” (NCT05095376)
“CLadribine tablets: Observational evaluation of effectIveness and patient-reported outcomes (PROs) in suboptimally Controlled patients previously taKing injectable disease-modifying drugs (DMDs) for relapsing forms of Multiple Sclerosis (RMS) (CLICK-MS)” (NCT03933215)

Children's Tumor Foundation – CTF-2022-12-002
“Adult NF Clinic Program Building Pilot Project”
Principal Investigator
07/01/22 – 06/30/24

Ercanbrack CW, Elhusseiny AM, Sanders RN, [et al., including Santos Horta E]. Belzutifan-induced regression of retinal capillary hemangioblastoma: A case-series. American journal of ophthalmology case reports. 2024 33:102011. PMID: 38374949. PMCID: PMC10875190.
Mathews AP, Shelton WJ, Horta ES, [et al.]. Operative planning for a functional precision medicine assay of recurrent high-grade glioma: illustrative case. Journal of neurosurgery. Case lessons. 2024 7(7). PMID: 38346299. PMCID: PMC10865468.
Battini S, Gokden M, Palys V, Santos Horta E. Diffuse Leptomeningeal Glioneuronal Tumor: First Description of Metastasis to the Lung and Bone Marrow. Cureus. 2023 15(11):e48185. PMID: 38050500. PMCID: PMC10693495.
Horta E, Burke-Smith C, Megna BW, [et al.]. Prevalence of cerebrovascular accidents in patients with ulcerative colitis in a single academic health system. Scientific reports. 2022 12(1):18668. PMID: 36333367. PMCID: PMC9636207.
Horta E, Bongiorno C, Ezzeddine M, Neil EC. Neurotoxicity of antibodies in cancer therapy: A review. Clinical neurology and neurosurgery. 2020 188:105566. PMID: 31731087.